India's largest drugmaker, Sun Pharma, will buy US-based Organon in an all-cash deal, including debt. Notably, Sun Pharma will be borrowing nearly $10 billion to fund $11.75-billion deal, Moneycontrol reported. Its management said deal should be judged not on short-term balance-sheet optics but on how decisively it accelerates firm's long-term transformation into a global pharmaceutical player.